Mar 02, 2017 14:30 pm UTC| Business
SAN FRANCISCO, March 02, 2017 -- Hagens Berman Sobol Shapiro LLP alerts investors in Graña y Montero S.A.A. (NYSE:GRAM) to the securities class action pending in the United States District Court for the Eastern District...
Investors look for ways to work assets harder
Mar 02, 2017 14:19 pm UTC| Business
ARLINGTON, Va., March 02, 2017 -- Leading global advisory, broking and solutions company, Willis Towers Watson’s (NASDAQ:WLTW) institutional clients — which include pension funds, sovereign wealth funds, endowments,...
Insys Therapeutics to Report Fourth Quarter and Full Year 2016 Results
Mar 02, 2017 14:18 pm UTC| Business
PHOENIX, March 02, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “Company”) today announced that the Company will release its financial results for the fourth quarter and full year 2016 on Thursday, March...
Diana Containerships Inc. Announces Time Charter Contract for m/v Great With OOCL
Mar 02, 2017 14:18 pm UTC| Business
ATHENS, Greece, March 02, 2017 -- Diana Containerships Inc. (NASDAQ:DCIX), (the “Company”), a global shipping company specializing in the ownership of containerships, today announced that, through a separate...
Aptean Enhances Software Update Process With the Verdiem EvokeIT Solution
Mar 02, 2017 14:10 pm UTC| Business
ALPHARETTA, Ga., March 02, 2017 -- Enterprise IT departments can now significantly reduce employee downtime resulting from software update disruptions by using Verdiem’s recently launched EvokeIT solution. Verdiem,...
Celebrating 25 Years of Changing Lives, Rosetta Stone Designates March as ‘Language Learning Month’
Mar 02, 2017 14:08 pm UTC| Business
Arlington, VA, March 02, 2017 -- Rosetta Stone Inc. (NYSE: RST), a leader in technology-based language and literacy solutions, is kicking-off its 25th Anniversary Celebration by designating March as “Language Learning...
Novan’s Phase 2 Results with SB206 to be Presented at 2017 AAD Annual Meeting
Mar 02, 2017 14:05 pm UTC| Business
MORRISVILLE, N.C., March 02, 2017 -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that data from the Company’s Phase 2 clinical trial with SB206 for the treatment of genital warts caused by human...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood